European Pharmaceutical Review

MARCH 9, 2023

Highly potent active pharmaceutical ingredients (HPAPIs) are used in formulations for high potent drugs, owing to their ability to target precise disease cells including cancer cells. It’s a collaborative approach from safety, engineering, toxicology, and operations to have the most robust potent compound safety.

Compounding 95

Compounding Dosage Communication 95

pharmaphorum

FEBRUARY 1, 2022

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

FDA 104

FDA 104

ISPE

OCTOBER 28, 2022

More than 400 attendees learned about the latest developments in biopharmaceuticals, cell and gene therapy, and ATMPs at the 2022 ISPE Biotechnology Conference , held 28–30 June in Boston, Massachusetts. One thing I never thought a lot about until the pandemic was fill-finish capacity, which turned out to be quite limiting early on.

Vaccines 52

Vaccines FDA Immunization 52

European Pharmaceutical Review

FEBRUARY 23, 2023

The second wave promises useful innovations for pharmaceuticals. This article presents an overview of Raman spectroscopy and details some of the developments of interest to the pharmaceutical sector. 5 For example, a research team discovered that Escherichia coli cells exposed to different environments had distinct Raman fingerprints.

Labelling 111

Labelling Packaging 111

Roots Analysis

OCTOBER 22, 2023

It is important to highlight that IVT mRNAs are structurally similar to natural mRNAs and can be used to express proteins through genetic engineering. His insights undergo rigorous editorial and peer-review processes, establishing his credibility as a thought leader within the pharmaceutical and healthcare domain.

Vaccines 40

Vaccines 40